Defining and diagnosing irritable bowel syndrome.

Area of Science:

• Gastroenterology
• Internal Medicine

Background:

• Irritable Bowel Syndrome (IBS) affects approximately 20% of the general population.
• While many with IBS do not seek medical attention, it accounts for a significant percentage of primary care and gastroenterology visits.
• The economic burden of IBS is substantial, with estimated annual costs of $8 billion due to direct and indirect expenses.

Purpose of the Study:

• To outline the diagnostic criteria and recommended investigations for Irritable Bowel Syndrome (IBS).
• To highlight the prevalence, clinical presentation, and economic impact of IBS.

Main Methods:

• Diagnosis of IBS is based on the Rome II criteria, which include abdominal pain or discomfort associated with altered bowel habits.
• Patients are subcategorized into constipation-predominant, diarrhea-predominant, or alternating constipation and diarrhea.
• Recommended initial investigations include hematology, fecal occult blood test, flexible sigmoidoscopy, and lactose intolerance evaluation.

Main Results:

• IBS is characterized by symptoms such as altered bowel habits, abdominal pain/discomfort, and bloating, without apparent structural pathology.
• Further testing may be indicated to exclude other gastrointestinal conditions like infections, pelvic floor dysfunction, or inflammatory bowel disease.

Conclusions:

• Accurate diagnosis of IBS relies on established criteria and a systematic approach to investigations.
• Effective management requires differentiating IBS from other conditions with similar symptoms.